Lactalis recalls additional infant, nutritional formula products from UAE
In a statement issued on Friday, the company said that as a precautionary measure, Lactalis Group had decided, in agreement with French authorities, a further product recall, which includes all infant and nutritional products manufactured and packed in Craon factory since February 15, 2017.
All other products manufactured in our other factories are safe and are out of the scope of recall.The company apologised to concerned families - and also assured that no case had been reported in UAE.
Following the alert transmitted by French authorities on December 1 , 2017 concerning a risk of salmonella contamination of infant formula, Lactalis Group proceeded on December 2, 2017 to a first withdrawal/ recall of products.Further investigations led to a second withdrawal/recall of all products manufactured since February 15, 2017 from one of the drying towers of the plant, according to the statement.
Batches recalled in UAE Three additional batches will be withdrawn/recalled from the Emirati market.Consumption of the products listed in the appendices must be stopped and replaced by alternative products.
The company decided to stop Craon factory for a drastic and complete audit on December 8, 2017 despite the conformity of all their analyzes carried out on finished products in between January 1, 2017 and December 1, 2017.Since the beginning of this crisis, a reinforced analysis program had been implemented with independent external laboratories.
The company discovered that dispersed contamination had settled in their Craon factory following work carried out during the first half of 2017.In the face of this fact, further precautionary measures had proved to be necessary.
Lactalisadded that it was committed to sharing the findings of an audit over the coming weeks.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment